Insider Transactions in Q3 2022 at Galectin Therapeutics Inc (GALT)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,736
+1.71%
|
$10,736
$1.79 P/Share
|
|
Sep 15
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,777
+1.59%
|
$9,777
$1.79 P/Share
|
|
Aug 31
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,211
+1.52%
|
$9,211
$1.9 P/Share
|
|
Aug 15
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,028
+1.35%
|
$16,056
$2.18 P/Share
|
|
Jul 29
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,606
+1.88%
|
$21,212
$2.26 P/Share
|
|
Jul 28
2022
|
Richard A. Zordani Jr. |
BUY
Open market or private purchase
|
Direct |
5,000
+14.46%
|
$10,000
$2.5 P/Share
|
|
Jul 22
2022
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$20,000
$2.09 P/Share
|
|
Jul 15
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,606
+1.91%
|
$10,606
$1.65 P/Share
|